Please assess the completion status of the following clinical trial:

Trial Title: Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Previous diagnosis of type 2 diabetes with a blood glucose level on admission greater than 180 mg/dl and treated with diet, any combination of oral antidiabetics agents and/or insulin therapy~Exclusion Criteria:~* Patients with hyperglycemia without a previous diagnosis of diabetes~* Patients with acute hyperglycemic emergencies or with severe hyperglycemia treated with intravenous insulin infusion on admission~* Patients with acute or chronic kidney disease (serum creatinine greater than 2 mg/dl),~* Patients treated with corticosteroids~* Patients with history of severe or repeated hypoglycemic episodes~* Pregnant women~* Patients expected to require ICU admission or less than 3 days of hospital stay

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Premixed insulin (Type: EXPERIMENTAL): Mixtard 30:70 Novonordisk® twice daily, before breakfast and before dinner.
- Basal-bolus (Type: EXPERIMENTAL): 'Lantus® once daily and Apidra® before meals

Based on this trial design, predict the completion outcome and termination type (if applicable).